UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$205M |
| 2 |
Johnson & Johnson
JNJ
|
+$186M |
| 3 |
Honeywell
HON
|
+$177M |
| 4 |
Mondelez International
MDLZ
|
+$132M |
| 5 |
Alibaba
BABA
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$270M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$212M |
| 3 |
Citigroup
C
|
+$185M |
| 4 |
Booking.com
BKNG
|
+$104M |
| 5 |
Intuitive Surgical
ISRG
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 14.47% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Communication Services | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
EOG Resources
EOG
$76.9B
| $251M | 0.28% |
3,012,393
+62,026
| +2% | +$4.97M |
|
77
Synchrony
SYF
$25.1B
| $248M | 0.28% |
9,810,514
+621,994
| +7% | +$18.1M |
|
78
Qualcomm
QCOM
$171B
| $248M | 0.28% |
4,628,708
-68,969
| -1% | -$3.63M |
|
79
Thermo Fisher Scientific
TMO
$216B
| $242M | 0.27% |
1,635,244
+305,607
| +23% | +$45.1M |
|
80
Vertex Pharmaceuticals
VRTX
$125B
| $239M | 0.27% |
2,778,670
-175,045
| -6% | -$15.1M |
|
81
DuPont de Nemours
DD
$18.8B
| $239M | 0.27% |
1,895,239
+230,739
| +14% | +$30.4M |
|
82
Duke Energy
DUK
$101B
| $235M | 0.27% |
2,738,615
+114,239
| +4% | +$9.13M |
|
83
Zimmer Biomet
ZBH
$18.6B
| $227M | 0.26% |
1,945,455
-44,511
| -2% | -$5.04M |
|
|
RAI
84
DELISTED
Reynolds American Inc
RAI
| $225M | 0.25% |
4,168,552
+362,803
| +10% | +$18.2M |
|
85
US Bancorp
USB
$99.6B
| $225M | 0.25% |
5,573,880
-266,832
| -5% | -$11.1M |
|
86
Infosys
INFY
$50B
| $223M | 0.25% |
24,972,978
+13,306,532
| +114% | +$124M |
|
87
Ross Stores
ROST
$80.4B
| $220M | 0.25% |
3,877,730
+276,277
| +8% | +$15.3M |
|
88
Check Point Software Technologies
CHKP
$14B
| $217M | 0.25% |
2,727,707
-787,726
| -22% | -$65.9M |
|
89
Occidental Petroleum
OXY
$55.3B
| $217M | 0.24% |
2,866,394
-103,088
| -3% | -$7.7M |
|
90
NextEra Energy
NEE
$188B
| $213M | 0.24% |
6,547,520
+580,268
| +10% | +$17.4M |
|
91
Halliburton
HAL
$26.4B
| $213M | 0.24% |
4,692,611
+551,951
| +13% | +$22.7M |
|
92
Colgate-Palmolive
CL
$73.6B
| $212M | 0.24% |
2,891,748
-59,276
| -2% | -$4.22M |
|
93
Southern Company
SO
$110B
| $211M | 0.24% |
3,930,291
+96,293
| +3% | +$4.84M |
|
94
Texas Instruments
TXN
$253B
| $208M | 0.24% |
3,327,805
-60,987
| -2% | -$3.63M |
|
|
95
S&P Global
SPGI
$123B
| $205M | 0.23% |
+1,914,020
| New | +$205M |
|
96
United Parcel Service
UPS
$88.9B
| $202M | 0.23% |
1,876,618
-22,406
| -1% | -$2.33M |
|
|
TWX
97
DELISTED
Time Warner Inc
TWX
| $201M | 0.23% |
2,734,213
+69,292
| +3% | +$5.13M |
|
98
Morgan Stanley
MS
$327B
| $199M | 0.22% |
7,652,934
-206,089
| -3% | -$5.39M |
|
99
Ingredion
INGR
$6.49B
| $197M | 0.22% |
1,524,504
+154,647
| +11% | +$18M |
|
100
American Express
AXP
$227B
| $196M | 0.22% |
3,217,946
+13,457
| +0.4% | +$852K |
|
Similar funds
UBS AM's Q2 2016 Portfolio in Review
As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
- UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
- UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
- UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
- UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
- UBS AM opened 65 new positions and closed 89 in Q2 2016.
- UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.
Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.